Fig. 4From: Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertensionProportion of patients who achieved sitting clinic systolic blood pressure and/or sitting clinic diastolic blood pressure response at week 6. AZL-M, azilsartan medoxomil; CI, confidence interval; scDBP, sitting clinic diastolic blood pressure; scSBP, sitting clinic systolic blood pressure; SE, standard errorBack to article page